By Linda Casale, MSN, RN, PMHN-BC

Medical Cannabis has gained significant attention for its therapeutic benefits in treating a variety of medical conditions. Derived from the Cannabis sativa plant, cannabinoids such as tetrahydrocannabinol (THC) and cannabidiol (CBD) interact with the body's endocannabinoid system to regulate various physiological processes. Evidence-based research highlights its efficacy in managing chronic pain, neurological disorders, mental health conditions, and many more.

This paper explores the broad spectrum of conditions effectively treated by medical Cannabis and provides insight into its role in symptom management, referencing key studies and clinical findings.

Pain Management and Inflammatory Conditions

Chronic pain is one of the most common reasons for medical Cannabis use. Both THC and CBD have shown effectiveness in reducing pain by modulating pain perception and inflammatory responses.

Neuropathic Pain:

Studies indicate that Cannabis is particularly effective for neuropathic pain, a condition often resistant to traditional treatments. A clinical trial (1) by Ware et al. (2010) demonstrated that inhaled Cannabis significantly reduced pain intensity in patients with chronic neuropathic pain.

Arthritis and Inflammatory Conditions:

CBD's anti-inflammatory properties make it a promising treatment for rheumatoid arthritis (2) and inflammatory bowel disease (IBD) (3). Another study (4) published in Rheumatology found that CBD reduced joint inflammation and improved mobility in animal models.

Neurological Disorders

The neuroprotective effects of cannabinoids have opened doors for treating various neurological conditions, particularly epilepsy, multiple sclerosis (MS), and Parkinson's disease.

Epilepsy:

One of the most well-documented uses of medical Cannabis is in managing treatment-resistant epilepsy. The FDA-approved drug Epidiolex, a CBD-based medication, has proven effective in reducing seizure frequency in conditions such as Dravet syndrome and Lennox-Gastaut syndrome. (5) (6) 

Multiple Sclerosis:

Cannabis-based treatments help alleviate spasticity, pain, and bladder dysfunction associated with MS. (7) A systematic review (8) by Koppel et al. (2014) concluded that oral Cannabis extracts significantly reduced MS-related spasticity.

Parkinson's Disease:

Preliminary research suggests that Cannabis may reduce tremors and improve sleep in Parkinson's patients, though more extensive clinical trials are needed to confirm these benefits.

Mental Health and Psychiatric Disorders

Cannabis has demonstrated mixed effects in mental health management, but emerging evidence supports its use in specific psychiatric conditions.

Anxiety Disorders:

Low doses of CBD have anxiolytic effects, helping reduce symptoms of generalized anxiety disorder, social anxiety, and post-traumatic stress disorder (PTSD). A systematic review (9) by Blessing et al. (2015) found that CBD significantly reduced anxiety symptoms in animal and human studies.

Post-Traumatic Stress Disorder (PTSD):

Medical Cannabis has shown promise in managing PTSD (10) (11) by reducing hyperarousal, anxiety, and intrusive memories. Veterans with PTSD have reported significant improvement in sleep and overall quality of life with Cannabis use.

Depression:

While the relationship between Cannabis and depression is complex, some studies suggest that CBD's antidepressant-like effects could help in managing mild to moderate depressive symptoms. (12)

Cancer and Palliative Care

Medical Cannabis plays a critical role in managing symptoms associated with cancer and its treatment, particularly pain, nausea, and loss of appetite.

Pain Management:

Cannabis provides an alternative to opioids in cancer pain management, reducing the risk of dependency and side effects.

Nausea and Vomiting:

THC has been used for decades to manage chemotherapy-induced nausea and vomiting (CINV). The American Society of Clinical Oncology (ASCO) recommends cannabinoids as a second-line treatment for CINV (13, 14).

Appetite Stimulation:

Cannabis can help combat cancer-related anorexia by stimulating appetite and improving patients' nutritional status and quality of life.

Gastrointestinal Disorders 

The endocannabinoid system plays a key role in regulating gut function, making medical Cannabis a potential treatment for gastrointestinal (GI) disorders.

Irritable Bowel Syndrome (IBS):

Cannabinoids may reduce intestinal inflammation and modulate gut motility, improving symptoms such as abdominal pain and bloating.

Crohn's Disease and Ulcerative Colitis:

Small clinical trials have shown that Cannabis can reduce disease activity and improve the quality of life for patients with Crohn's disease and ulcerative colitis. (15) (16)

Sleep Disorders

Cannabis, particularly varieties high in THC, can help treat sleep disorders such as insomnia and sleep apnea.

Insomnia:

Research shows that Cannabis reduces sleep latency (the time it takes to fall asleep) and increases overall sleep duration.

Obstructive Sleep Apnea (OSA):

Preliminary studies suggest that dronabinol, a synthetic form of THC, may reduce the frequency of apnea episodes in OSA patients. (17)

 p

Dermatological Conditions

Recent research highlights the potential of topical cannabinoids in treating skin conditions due to their anti-inflammatory and antimicrobial properties.

Psoriasis and Eczema:

CBD-infused topicals have effectively reduced inflammation and itching associated with psoriasis and eczema. (18) 

Acne:

CBD's ability to reduce sebum production and its anti-inflammatory properties make it a promising acne treatment (19) (20). 

Pediatric Use of Medical Cannabis

While pediatric use is controversial, certain conditions have seen positive outcomes with medical Cannabis, particularly CBD-based treatments.

Severe Epilepsy:

As mentioned, Epidiolex has transformed the management of pediatric epilepsy.

Autism Spectrum Disorder (ASD):

Preliminary studies suggest that CBD may help reduce aggression, self-injury, and anxiety in children with ASD. (21) (22) 

Ongoing Research and Future Directions

Despite the growing body of evidence supporting medical Cannabis, ongoing research is a crucial and engaging aspect of its future. This research is needed to establish optimal dosing, long-term safety, and efficacy across various conditions.

Areas of active investigation include its role in treating Alzheimer's disease, glaucoma, and autoimmune disorders. Additionally, research is focusing on the development of targeted Cannabis-based therapies that minimize psychoactive effects while maximizing therapeutic potential, keeping the audience engaged and interested in the future of medical Cannabis.

Conclusion

Medical Cannabis, with its versatile and practical treatment options, offers reassurance for a wide range of conditions and symptoms. From chronic pain and neurological disorders to mental health conditions and cancer-related symptoms, its therapeutic potential continues to expand. While more extensive clinical trials are needed to refine its use, current evidence underscores its significant role in modern medicine. As regulatory barriers ease and research advances, the future of medical Cannabis looks promising for both patients and healthcare providers.

References

1.  Ware MA., et al. (2010). Smoked cannabis for chronic neuropathic pain: a randomized controlled trial. CMAJ. 

2. Paland N., et al.(2023). Cannabis and Rheumatoid Arthritis: A Scoping Review Evaluating the Benefits, Risks, and Future Research Directions. Rambam Maimonides Medical Journal

3. Nduma BN., et al (2023). The Use of Cannabinoids in the Treatment of Inflammatory Bowel Disease (IBD): A Review of the Literature. 

4. Philpott, H., et al. (2017). Anti-inflammatory effects of cannabidiol in experimental arthritis. European Journal of Pain.

 5. Anne T., et al. (2024). Caregiver-reported outcomes with real-world use of cannabidiol in Lennox-Gastaut syndrome and Dravet syndrome from the BECOME survey.

6. Devinsky, O., et al. (2018). Trial of cannabidiol for drug-resistant seizures in the Dravet syndrome. New England Journal of Medicine.

7. Haddad F., et al. (2022). The Efficacy of Cannabis on Multiple Sclerosis-Related Symptoms. Life (Basel). 

8. Koppel, B. S., et al. (2014). Systematic review: Efficacy and safety of medical marijuana in selected neurologic disorders. Neurology. 

9. Blessing, E. M., et al. (2015). Cannabidiol is a potential treatment for anxiety disorders. Neurotherapeutics.

10. Rehman, Y., et al. (2021). Cannabis in the management of PTSD: a systematic review. 
AIMS Neuroscience.

11.  Elms, L., et al. (2019). A retrospective review of medical Cannabis in PTSD patients. Journal of Psychoactive Drugs.

12. Gallego-Landin, I., et al. (2021). Reviewing the Role of the Endocannabinoid System in the Pathophysiology of Depression. Frontiers in Pharmacology.

13. Sukpiriyagul, A., et al. (2023). Oral Tetrahydrocannabinol (THC): Cannabinoid (CBD) Cannabis Extract Adjuvant for Reducing Chemotherapy-Induced Nausea and Vomiting (CINV): A Randomized, Double-Blinded, Placebo-Controlled, Crossover Trial. Int J Womens Health.

14. Abrams, D. I., & Guzman, M. (2015). Cannabis in cancer care. Clinical Oncology.

15. Aloisio, C., et al. (2025). The Endocannabinoid System: Implications in Gastrointestinal Physiology and Pathology. International Journal of Molecular Sciences.

16. Naftali, T., et al. (2013). Cannabis induces clinical improvement in Crohn's disease: A prospective placebo-controlled study. Clinical Gastroenterology and Hepatology. 

17. Prasad, B., et al. (2013). Proof of concept trial of dronabinol in obstructive sleep apnea. Front Psychiatry.

18.  Palmieri, B., et al. (2019). A therapeutic effect of cbd-enriched ointment in inflammatory skin diseases and cutaneous scars. Clinicaterapeutica.

19. Lee, J.H., Yoon, J.Y., Kim, D.H. et al. Potential of cannabidiol as acne and acne scar treatment: novel insights into molecular pathways of pathophysiological factors. Arch Dermatol Res. 

20. Oláh et al., (2014). Cannabidiol exerts sebostatic and antiinflammatory effects on human sebocytes. The Journal of Clinical Investigation. 

21. Jawed, B., et al. (2024) The Evolving Role of Cannabidiol-Rich Cannabis in People with Autism Spectrum Disorder: A Systematic Review. Int. J. Mol. Sci.

22. Aran, A., et al. (2021). Cannabinoid treatment for autism: a proof-of-concept randomized trial
  

About Linda Casale:

Linda Casale, MSN, RN, PMHN-BC, Certified Cannabis Nurse on the Board of Directors of the National Alliance on Mental Illness (NAMI) of Palm Beach County.  Owner of Veterans' Victories. This organization assists veterans in transitioning back into civilian life, recovering from PTSD and other traumas, and learning how to live a holistic life. Lindia has participated in numerous other organizations as a retired VA nurse of twenty-five years.

Click the Learn More Button 

 Effective Cannabis Newsletter is a platform to educate on the vital role of the Endocannabinoid System (ECS) in one's health. The information is not intended or implied to be a substitute for professional medical advice, diagnosis, or treatment. All content, including text, graphics, images, and information, contained in or available through this newsletter is for general information purposes only. It is not medical advice; it is health awareness.